Open access · OA
via Europe PMC
A 2-year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance
Authors not listed
Innovation in aging · 2025
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-07-01 MST
Cite this
APA
Anonymous. (2025). A 2-year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance. <em>Innovation in aging</em>. https://europepmc.org/article/PMC/PMC12762609
Vancouver
Anonymous. A 2-year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance. Innovation in aging. 2025.
BibTeX
@article{anon2025AyearT,
title = {A 2-year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance},
author = {Anonymous},
journal = {Innovation in aging},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Innovation in aging 2025
Open access · OA
METFORMIN TO TARGET FRAILTY IN OLDER ADULTS
VA Office of Research and Development 2021
Open access · US-GOV
Lifestyle Intervention Plus Metformin to Treat Frailty in Older Veterans With Obesity
GeroScience 2020
Preprint · OA
Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis
Neslihan Lok 2025
Open access · US-GOV
Effects of a Multicomponent Exercise Program on Frailty, Cognitive Function, and Sleep Quality in Older Adults: A Randomized Controlled Trial
Oregon Health and Science University 2024
Open access · US-GOV
Safety, Tolerability, and Pharmacokinetics of an Oral Withania Somnifera Product in Older Adults
The University of Texas Health Science Center at San Antonio 2019
Open access · US-GOV